Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

SHE:000597 Revenue

Northeast Pharmaceutical Group had revenue of 1.33B CNY in the quarter ending June 30, 2026, a decrease of -30.36%. This brings the company's total for the last twelve months to 6.56B, down -8.79% year-over-year. In the year 2025, Northeast Pharmaceutical Group had annual revenue of 7.07B, down -5.70%. That makes Northeast Pharmaceutical Group the 7,696th largest company in the world by revenue and 1,124th in China.

• Revenue (ttm): 6.56B
• Revenue Growth: -8.79%
• P/S Ratio: 0.98
• Revenue / Employee: 1.14M
• Employees: 5,727
• Market Cap: 6.41B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing 3.90B 55.1%
• Pharmaceutical Business 3.03B 42.8%
• Others 150.09M 2.1%

By Geography

Chart

• China 5.99B 84.6%
• Export 1.09B 15.4%

Fiscal year ended Dec 31, 2025 See the full SHE:000597 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.07B	-427.70M	-5.70%
Dec 31, 2024	7.50B	-740.62M	-8.98%
Dec 31, 2023	8.24B	-565.77M	-6.42%
Jan 1, 2023	8.81B	663.83M	8.15%
Dec 31, 2021	8.15B	760.76M	10.30%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error